Angelini Pharma and Quiver Partner to Advance Genetic Epilepsies
Angelini Pharma and Quiver Bioscience have announced a strategic research collaboration and licensing agreement. The collaboration aimed at accelerating the discovery of new therapies for genetic epilepsies. Under the multi-year agreement, Angelini Pharma will receive e.. Read the news
